Lv51
1350 积分 2020-08-12 加入
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse
13天前
已完结
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
23天前
已完结
MRD intervention in AML: A new therapeutic horizon
23天前
已完结
A clinical guide to TP53 mutations in myeloid neoplasms
23天前
已完结
TP53-Mutated Acute Myeloid Leukemia: How Can We Improve Outcomes?
23天前
已完结
Autologous or allogeneic hematopoietic stem cell transplantation as front-line treatment for adult secondary acute myeloid leukemia patients: the PETHEMA registry experience
25天前
已完结
Autologous or allogeneic hematopoietic stem cell transplantation as front-line treatment for adult secondary acute myeloid leukemia patients: the PETHEMA registry experience
25天前
已完结
Efficacy of haploidentical allogeneic hematopoietic cell transplantation following two courses of venetoclax and azacytidine therapy in patients over 55 years old with acute myelogenous leukemia
1个月前
已完结
Indolent CD8+ CAR T-Cell Lymphoma of the Gastrointestinal Tract after Ciltacabtagene Autoleucel Therapy for Relapsed/Refractory Multiple Myeloma
1个月前
已关闭
Genomic Landscape of Mixed Phenotype Acute Leukemia Associated With Immunophenotypic Lineage Predominance: Impact on Diagnosis and Treatment
1个月前
已完结
皖公网安备34019202002308
